---
phase: 01-live-evidence-revalidation
plan: 19
subsystem: testing
tags: [unit-tests, mutation-testing, plugin-handlers, evidence-ledger]
requires:
  - phase: 01-01
    provides: Normalized evidence shard schema, assignment validator, and locked corpus inventory
provides:
  - Claim-complete live adjudication of the plugin-handler adversarial review
  - Current isolated mutation evidence for the list flag boundary and tautological catalog gate
  - Positive stale proof replacing the historical absence of runtime verification
affects: [phase-02-remediation, plugin-handler-tests, architecture-gates, shard-merge]
actuals:
  tokens: 10918
  tasks: 1
  commits: 1
tech-stack:
  added: []
  patterns: [isolated mutation copies, source-claim canonical linking, positive stale proof]
key-files:
  created:
    - .planning/phases/01-live-evidence-revalidation/shards/01-19.json
    - .planning/phases/01-live-evidence-revalidation/01-19-SUMMARY.md
  modified: []
key-decisions:
  - "Keep handler-to-orchestrator ownership fixes routed to Phase 2 while preserving full-value assertions until narrow injection seams exist."
  - "Retain the update omitted-scope observation and workspace-helper consolidation in the deferred backlog because they cross this shard's handler ownership boundary."
patterns-established:
  - "A catalog gate derived from the same production expression on both sides requires an isolated mutation, not a passing baseline test, to prove its weakness."
  - "A historical no-test limitation becomes stale only after a named current focused rerun supplies positive replacement evidence."
requirements-completed: [RVAL-01, RVAL-02]
coverage:
  - id: D1
    description: The assigned plugin-handler corpus file has complete namespaced claims and terminal reconciled findings.
    requirement: RVAL-01
    verification:
      - kind: other
        ref: "node scripts/revalidation.mjs validate-shard --assignment .planning/phases/01-live-evidence-revalidation/01-CORPUS-ASSIGNMENT.md --plan 01-19 --shard .planning/phases/01-live-evidence-revalidation/shards/01-19.json"
        status: pass
    human_judgment: false
  - id: D2
    description: Current evidence distinguishes live plugin-handler weaknesses from stale historical limitations without modifying live production or test files.
    requirement: RVAL-02
    verification:
      - kind: unit
        ref: "node --test tests/edge/handlers/plugin/*.test.ts tests/architecture/flag-catalog-drift.test.ts"
        status: pass
      - kind: other
        ref: "repository-local isolated mutations for list single-dash classification and the list catalog drift assertion"
        status: pass
    human_judgment: false
duration: 12min
completed: 2026-09-04
status: complete
---

# Phase 01 Plan 19: Plugin Handler Evidence Revalidation Summary

**Thirty-four historical plugin-handler claims now have terminal current dispositions backed by live call-graph inspection, focused offline tests, and two surviving isolated mutations.**

## Performance

- **Duration:** 12 min
- **Started:** 2026-09-04T22:53:00Z
- **Completed:** 2026-09-04T23:05:17Z
- **Tasks:** 1
- **Files modified:** 1 evidence shard

## Accomplishments

- Reconciled the assigned 44,826-byte adversarial report into 34 independently traceable source claims and 21 canonical findings.
- Confirmed 20 live findings, including test-only production exports, handler-to-orchestrator ownership leakage, a single-dash classification mutation, and a catalog assertion that cannot detect its named drift.
- Positively closed the historical no-runtime-verification limitation after all 13 current focused suites passed.
- Kept evidence status independent from routing: 15 findings route to Phase 2, two remain deferred backlog items, and four close evidence-only.

## Task Commits

1. **Task 1: Individually adjudicate corpus record 031** — `0b39ecee` (docs; root commit after executor Git-metadata gate)

## Files Created/Modified

- `.planning/phases/01-live-evidence-revalidation/shards/01-19.json` — Exclusive validated evidence shard for the assigned plugin-handler report.
- `.planning/phases/01-live-evidence-revalidation/01-19-SUMMARY.md` — Execution record and evidence overview.

## Decisions Made

- Preserved whole-value handler assertions until narrow orchestration ports replace downstream workflow ownership; weakening assertions is not an acceptable interim fix.
- Routed the nine plugin handler injection seams as coordinated Phase 2 work and retained `import.test.ts` as the precise interaction-testing reference.
- Deferred workspace-helper consolidation until seam work determines which filesystem setup remains necessary.
- Preserved the update omitted-scope observation for adjudication by the update-orchestrator corpus owner instead of changing handler behavior.

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered

- The executor sandbox could not write the linked parent Git metadata. The root orchestrator committed the validated shard as `0b39ecee`; no branch or worktree isolation was altered.
- Documentation and tracking updates remain intentionally unstaged for the root orchestrator because the linked Git metadata is read-only in this executor.

## Known Stubs

None.

## Threat Flags

None. The plan changed only normalized planning evidence. Both mutations ran inside a repository-local isolated copy that was removed afterward; live production and test files remained unchanged.

## User Setup Required

None - no external services, credentials, network access, or real user state were used.

## Next Phase Readiness

- The 01-19 shard is ready for deterministic merge after the remaining review plans complete.
- Confirmed export, gate, injection-seam, assertion-control, fixture, and documentation findings are traceably routed for Phase 2.
- Cross-owner workspace consolidation and update scope semantics remain explicit deferred items rather than silent assumptions.

## Self-Check: PASSED

The shard and summary exist; root task commit `0b39ecee` is present; the assigned file is complete with 34 claims and 21 terminal findings; the assignment validator passes; all 13 focused suites pass; and isolated mutations never touched live source or test files.

---

_Phase: 01-live-evidence-revalidation_
_Completed: 2026-09-04_
